Patents by Inventor Ernest D. Bush

Ernest D. Bush has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190167640
    Abstract: The present invention relates to, inter alia, treatment of muscle dystrophy (e.g., Duchenne Muscular Dystrophy), for example, using a composition, e.g., a composition comprising Compound (I), or a pharmaceutically acceptable salt, prodrug or metabolite thereof.
    Type: Application
    Filed: October 24, 2018
    Publication date: June 6, 2019
    Inventors: Ernest D. Bush, Francois Nique, Catherine Jagerschmidt, Florence Sylvie Namour, Roland Blanque, Jean-Michel Lefrancois, Christophe Peixoto, Pierre Deprez, Nicholas Triballeau, Piet Tom Burt Paul Wigerinck
  • Publication number: 20180193276
    Abstract: Oral and parenteral dosage forms comprising halofuginone, including enteric-coated solid oral dosage forms, subcutaneous dosage forms and intravenous dosage forms, for administration to subjects in need thereof, e.g., subjects having been identified with musculoskeletal disorders, fibrotic diseases, malaria, or cancer are described herein.
    Type: Application
    Filed: September 20, 2017
    Publication date: July 12, 2018
    Inventors: Ernest D. Bush, Diane Mcguire, Marc B. Blaustein
  • Publication number: 20160250188
    Abstract: The present invention relates to, inter alia, treatment of muscle dystrophy (e.g., Duchenne Muscular Dystrophy), for example, using a composition, e.g., a composition comprising Compound (I), or a pharmaceutically acceptable salt, prodrug or metabolite thereof.
    Type: Application
    Filed: October 24, 2014
    Publication date: September 1, 2016
    Inventors: Ernest D. Bush, Francois Nique, Catherine Jagerschmidt, Florence Sylvie Namour, Roland Blanque, Jean-Michel Lefrancois, Christophe Peixoto, Pierre Deprez, Nicolas Triballeau, Piet Tom Burt Paul Wigerinck
  • Publication number: 20150086627
    Abstract: Oral and parenteral dosage forms comprising halofuginone, including enteric-coated solid oral dosage forms, subcutaneous dosage forms and intravenous dosage forms, for administration to subjects in need thereof, e.g., subjects having been identified with musculoskeletal disorders, fibrotic diseases, malaria, or cancer are described herein.
    Type: Application
    Filed: March 29, 2013
    Publication date: March 26, 2015
    Applicant: HALO THERAPEUTICS, LLC.
    Inventors: Ernest D. Bush, Diane Mcguire, Marc B. Blaustein